The purpose of this study is to demonstrate that telotristat etiprate does not differ from
placebo in the mean change from Baseline QT interval corrected for heart rate.
Phase:
Phase 1
Details
Lead Sponsor:
Lexicon Pharmaceuticals
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination